Matching slides 39,432
Current window 481-510
Pages 1,315
Rows per page 30
Arc: Consultants Gambitclear collectionreset all

Arc

481-510 of 39,432

filter-aware
05
The chart uses a combination of a line (investment/risk) and bars (cash flow) to visualize the drug development lifecycle.AbCellera | Investor Conference Presentation Deck | 25 slides · AbCellera
Conference presentation Investor relations Beat · Situation & ContextLoop · Cost Of Inaction2 hits
03
The slide uses a combination of pie charts for global statistics and a process diagram for supply chain loss.AgroFresh | Investor Conference Presentation Deck | 21 slides · AgroFresh
Conference presentation Investor relations Beat · Situation & ContextLoop · Cost Of Inaction2 hits
03
The slide uses a combination of pie charts for global statistics and a process diagram for supply chain loss.AgroFresh | Investor Conference Presentation Deck | 21 slides · AgroFresh
Conference presentation Investor relations Beat · Situation & ContextLoop · Cost Of Inaction2 hits
04
AgroFresh | Investor Conference Presentation Deck | 21 slidesAgroFresh | Investor Conference Presentation Deck | 21 slides · AgroFresh
Conference presentation Investor relations Beat · Situation & ContextLoop · Cost Of Inaction2 hits
05
The circular diagram acts as a value chain representation.AgroFresh | Investor Conference Presentation Deck | 21 slides · AgroFresh
Conference presentation Investor relations Beat · Situation & ContextLoop · Cost Of Inaction2 hits
06
AgroFresh | Investor Conference Presentation Deck | 21 slidesAgroFresh | Investor Conference Presentation Deck | 21 slides · AgroFresh
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction2 hits
11
The circular diagram represents a flywheel or strategic cycle of growth.AgroFresh | Investor Conference Presentation Deck | 21 slides · AgroFresh
Conference presentation Investor relations Beat · Evidence & Proof2 hits
12
AgroFresh | Investor Conference Presentation Deck | 21 slidesAgroFresh | Investor Conference Presentation Deck | 21 slides · AgroFresh
Conference presentation Investor relations Beat · Evidence & Proof2 hits
13
The slide uses a table-like structure to map product categories to performance commentary.AgroFresh | Investor Conference Presentation Deck | 21 slides · AgroFresh
Conference presentation Investor relations Beat · Evidence & Proof2 hits
17
Includes a medical illustration of brain pathways related to wakefulness and neurotransmitters.Alkermes | Investor Presentation Deck | 32 slides · Alkermes
Research note Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction2 hits
08
The slide uses a combination of bar charts and a central big-number metric to illustrate growth targets.Apollo Global Management | Mergers and Acquisitions Presentation Deck | 9 slides · Apollo Global Management
Deck Investment bank Beat · Solution & ApproachLoop · Logic Chain2 hits
06
The slide uses a four-column layout to structure the disease overview.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Situation & ContextLoop · Logic Chain2 hits
07
Uses a nested circle diagram to represent the patient funnel (Total -> Diagnosed -> Treated).Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Problem & ComplicationLoop · Logic Chain2 hits
10
The slide outlines the study structure for a clinical trial, categorizing cohorts by dosage and patient status (HBV DNA +/-).Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & ApproachLoop · Cost Of Inaction2 hits
11
Data table includes standard error (SE) values for each mean. Footnote provides specific study parameters.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & ApproachLoop · Cost Of Inaction2 hits
12
The slide displays longitudinal data for cohorts E, F, I, J, G, and K, with specific callouts for individual patient outcomes.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & ApproachLoop · Cost Of Inaction2 hits
13
The slide displays 8 individual patient charts tracking three biomarkers over 64 weeks. Two patients (53 and 58) show NA retreatment periods.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & ApproachLoop · Cost Of Inaction2 hits
14
Data presented at EASL 2022. Shows longitudinal patient data for patients 42, 43, and 48.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & ApproachLoop · Cost Of Inaction2 hits
15
The slide uses a bulleted list to present clinical safety findings.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & ApproachLoop · Cost Of Inaction2 hits
16
The slide uses a four-column layout to present key findings from a clinical trial.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & ApproachLoop · Cost Of Inaction2 hits
27
Includes a checkmark indicating completion of one milestone.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & Approach2 hits
28
Arbutus Biopharma | Investor Presentation Deck | 28 slidesArbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & Approach2 hits
15
The slide uses a table-like structure with categories on the left and bulleted assumptions on the right.Citi | Investment Banking Pitch Book | 20 slides · Citi
Consulting deck Investment bank Beat · Solution & ApproachLoop · Mece Breakdown2 hits
16
Includes detailed footnotes regarding adjustments, tax rates, and source data.Citi | Investment Banking Pitch Book | 20 slides · Citi
Consulting deck Investment bank Beat · Solution & ApproachLoop · Mece Breakdown2 hits
17
Includes a disclaimer about the preliminary nature of the data and specific assumptions regarding tax rates and debt.Citi | Investment Banking Pitch Book | 20 slides · Citi
Consulting deck Investment bank Beat · Solution & Approach2 hits
16
The diagram uses a funnel-like shape to represent the convergence of strategic pillars into a single outcome.J.P.Morgan | Investment Banking Pitch Book | 41 slides · JPMorgan
Consulting deck Investment bank Beat · Impact & Next StepsLoop · Quick Win Big Bet2 hits
17
Part of a valuation summary for Project Plato.J.P.Morgan | Investment Banking Pitch Book | 41 slides · JPMorgan
Consulting deck Investment bank Beat · Impact & Next StepsLoop · Quick Win Big Bet2 hits
18
J.P.Morgan | Investment Banking Pitch Book | 41 slidesJ.P.Morgan | Investment Banking Pitch Book | 41 slides · JPMorgan
Consulting deck Investment bank Beat · Impact & Next StepsLoop · Quick Win Big Bet2 hits
19
Data as of 3/6/2006.J.P.Morgan | Investment Banking Pitch Book | 41 slides · JPMorgan
Consulting deck Investment bank Beat · Impact & Next StepsLoop · Quick Win Big Bet2 hits
04
Uses the 'Rule of 50' framework (Revenue Growth + Adj. Operating Margin).Starboard Value | Activist Presentation Deck | 14 slides · Starboard Value
Activist deck Activist investor Beat · Situation & ContextLoop · Benchmark Gap2 hits